CellaVision AB (STU:C26)
€ 23.1 -0.65 (-2.74%) Market Cap: 559.99 Mil Enterprise Value: 558.02 Mil PE Ratio: 44.65 PB Ratio: 8.76 GF Score: 98/100

Q1 2019 CellaVision AB Earnings Call Transcript

May 07, 2019 / 09:00AM GMT
Release Date Price: €27.85 (+0.72%)
Operator

Ladies and gentlemen, welcome to the CellaVision AB audiocast and teleconference Q1 2019. Today, I am pleased to present CEO, Mr. Zlatko Rihter. (Operator Instructions) Speaker, please begin.

Zlatko Rihter;publ;President;CEO
CellaVision AB

()-&

Good morning, everybody. It's Zlatko here from Lund. Together with me today, I have as always, Magnus Blixt, our CFO; and Maria Morin, who is Head of HR and Corporate Communications. So there are 3 of us to support you today.

And of course, I will head into the presentation as usual and we'll ask for -- moving to the next slide, Slide #3 please.

And just the kind of update on CellaVision in short and also give an update on kind of our mission. Again, we have a mission to replace traditional microscopes in laboratories. And so far we're focused on hematology, which is blood analysis, and we also believe strongly that we have a very attractive offering since we both can offer improved patient diagnostics and also at the same time have a very strong case

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot